[1] Lee PA,Houk CP,Ahmed SF,et al.Consensus statement on management of intersex disorders[J].Pediatrics,2006,118(2):e488-500. [2] Barseghyan H,Délot E,Vilain E.New genomic technologies:an aid for diagnosis of disorders of sex development[J].Horm Metab Res,2015,47(5):312-320. [3] Larson A,Nokoff NJ,Travers S.Disorders of sex development:clinically relevant genes involved in gonadal differentiation[J].Discov Med,2012,14(78):301-309. [4] Savchuk I,Morvan ML,Antignac JP.A genomic atlas of human adrenal and gonad development[J].Endocr Connect,2017,6(6):348-359. [5] Baxter RM, Vilain E.Translational genetics for diagnosis of human disorders of sex development[J].Annu Rev Genomics Hum Genet,2013,14:371-392. [6] Bruque CD,Delea M,Fernandez CS,et al.Structure-based activity prediction of CYP21A2 stability variants:A survey of available gene[J].Sci Rep,2016,6:39082. [7] Biason Lauder A.WNT4,RSPO1,and FOXL2 in sex development[J].Semin Reprod Med,2012,30(5):387-395. [8] Camats N,Pandey AV,Fernandez-Cancio M,et al.The novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals[J].J Clin Endocrinol Metab,2012,97(7):E1294-E1306. [9] 刘国昌,李忠民,汪凤华,等.邻苯二甲酸二丁酯影响雄性大鼠性器官发育的作用机制研究[J].临床小儿外科杂志,2010,9(5):341-344. [10] Zhang Q,Zou P,Zhan H,et al.Dihydrolipoamide dehydrogenase and cAMP are associated with calnium-mediated Leydig cell damage[J].Toxicol Let,2011,205(2):183-189. [11] Segner H.Zebrafish(Danio rerio)as a model organism for investigating endocrine disruption[J].Comp Biochem Physiol C Toxicol Pharmacol,2009,149(2):187-195. [12] Someda S,Fukami M,Fujimoto M,et al.Association of micropenis with Pro185Ala polymorphism of the gene for aryl hydrocarbon receptor repressor involved in dioxin signaling[J].Endocr J,2005,52(1):83-88. [13] Zhang XF,Zhang LJ,Feng YN,et al.Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells[J].Mol Biol Rep,2012,39(9):8621-8628. [14] Bromer JG,Zhou Y,Taylor MB,et al.Bisphenol A exposure in utero leads to epigenetic alteration in the developmental programming of uterine estrogen response[J].FASEB J,2010,24(7):2273-2280. [15] Hughes IA.Disorders of sex development:a new definition and classification[J].Best Pract Res Clin Endocrinol Metab,2008,22(1):119-134. [16] Ahmed SF,Rodic M.Investigation and initial management of ambiguous genitalia[J].Best Pract Res Clin Endocrinol Metab,2010,24(2):197-218. [17] Ahmed SF,Achermann JC,Arlt W,et al.Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development(Revised 2015) [J].Cli Endocrinol(Oxf),2011,75(1):12-26. [18] 颜纯,王慕逖.小儿内分泌学[M].北京:人民卫生出版社,2006:366-368. [19] Sandberg DE,Pasterski V,Callens Nina.Introduction to the special section:Disorders of sex development[J].J Pediatr Psychol,2017,42(5):487-495. [20] Warne GL,Bhatia V.Intersex,east and west[M]//Sytsma S.Ethic and intersex.Berlin:Springer,2006:183-205. [21] Vidal I,Gorduza DB,Haraux E,et al.Surgical options in disorders of sex development(DSD) with ambiguous genitalia[J].Best Pract Res Clin Endocrinol Metab,2010,24(2):311-324. [22] 唐达星,付君芬.性别发育异常的新认识及外科选择[J].中华小儿外科杂志,2016,37(7):481-484. [23] Kolon TF,Herndon CD,Baker LA,et al.Evaluation and treatment of cryptorchidism:AUA guideline[J].J Urol,2014,192(2):337-345. [24] Dason S,Wong N,Braga LH.The contemporary role of 1 vs 2 stage repair for proximal hypospadias[J].Transl Androl Urol,2014,3(4):347-358. [25] 罗小平,应艳琴.关注儿童性发育障碍疾病的诊治[J].中国实用儿科杂志,2013,28(10):721-724.
|